Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
SURGERY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Large	O
ampullary	O
mass	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___:	O
Pylorus	O
sparing	O
radical	O
pancreatoduodenectomy,	O
-	O
22	O
modifier.	O
History	O
of	O
Present	O
Illness:	O
The	O
patient	O
is	O
a	O
___	O
w	O
___	O
CAD,	O
colon	O
cancer	O
s/p	O
R	O
colectomy,	O
CKD,	O
who	O
presented	O
to	O
OSH	O
on	O
___	O
with	O
abdominal	O
pain,	O
lipase	O
2,345,	O
Tbili	O
4.4	O
and	O
Dbili	O
of	O
3.4.	O
His	O
Cr	O
at	O
the	O
time	O
was	O
1.6.	O
US	O
at	O
that	O
time	O
showed	O
dilated	O
CBD	O
to	O
1.3cm	O
and	O
no	O
stones.	O
He	O
underwent	O
ERCP	O
at	O
___	O
but	O
they	O
were	O
unable	O
to	O
cannulate	O
after	O
seeing	O
a	O
large	O
ampullary	O
mass.	O
His	O
lipase	O
came	O
down	O
to	O
1778	O
and	O
his	O
Tbili	O
to	O
3.1.	O
He	O
was	O
transferred	O
for	O
further	O
workup	O
and	O
repeat	O
ERCP.	O
He	O
arrived	O
in	O
stable	O
condition	O
without	O
pain	O
and	O
was	O
taken	O
for	O
repeat	O
ERCP	O
where	O
again	O
a	O
large	O
ampullary	O
mass	O
was	O
seen.	O
Biopsies	O
were	O
taken	O
and	O
cannulation	O
was	O
unsuccessful.	O
The	O
patient	O
underwent	O
placement	O
of	O
PTBD	O
catheter.	O
NJ	O
was	O
palced	O
for	O
tubefeed	O
to	O
optimize	O
nutritional	O
status.	O
Patient	O
was	O
evalaued	O
by	O
Dr.	O
___	O
possible	O
___	O
procedure.	O
During	O
his	O
hospitalization	O
patient	O
was	O
evaluated	O
by	O
Cardiology	O
and	O
was	O
cleared	O
for	O
surgery.	O
The	O
pattient	O
present	O
today	O
for	O
elective	O
surgical	O
resection.	O
Past	O
Medical	O
History:	O
CAD	O
s/p	O
cardiac	O
stents	O
x	O
3,	O
CKD	O
stage	O
II-	O
III,	O
HTN,	O
Dyslipidemia,	O
Gout,	O
Obesity,	O
Colon	O
CA,	O
h/o	O
C.	O
diff	O
PSH:	O
Colon	O
CA	O
s/p	O
hemicolectomy-	O
last	O
colonoscopy	O
___	O
where	O
a	O
polyp	O
seen	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
had	O
___	O
lymphoma	O
and	O
died	O
of	O
complications	O
-	O
?	O
heart	O
failure.	O
His	O
father	O
died	O
of	O
an	O
MI	O
in	O
his	O
___.	O
There	O
is	O
no	O
family	O
h/o	O
GB	O
disease.	O
Physical	O
Exam:	O
Vital	O
signs:	O
Temperature:	O
99.8,	O
heart	O
rate:	O
76,	O
blood	O
pressure:	O
135/84,	O
respiratory	O
rate:	O
18,	O
O2	O
saturation:	O
98%	O
on	O
room	O
air.	O
The	O
patient	O
is	O
in	O
no	O
acute	O
distress.	O
AOx3	B-Delirium
Chest:	O
regular	O
hear	O
rate	O
and	O
rhythm,	O
normal	O
S1,	O
S2.	O
Lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally.	O
Abdomen:	O
Incision	O
well	O
healed,	O
clean,	O
dry	O
and	O
intact.	O
G-tube	O
in	O
position	O
capped.	O
J-tube	O
in	O
position.	O
No	O
signs	O
of	O
infection	O
in	O
G/J-tube	O
insertion	O
site.	O
JP	O
in	O
place,	O
draining	O
creamy	O
material	O
in	O
character.	O
PTBD	O
catheter	O
capped.	O
Soft,	O
non-tender	O
to	O
palpation,	O
non-distended.	O
Extremities:	O
without	O
edema.	O
Pertinent	O
Results:	O
___	O
10:00PM	O
TYPE-ART	O
PO2-224*	O
PCO2-38	O
PH-7.37	O
TOTAL	O
CO2-23	O
BASE	O
XS--2	O
___	O
10:00PM	O
GLUCOSE-193*	O
LACTATE-1.8	O
___	O
10:00PM	O
freeCa-1.13	O
___	O
09:51PM	O
GLUCOSE-197*	O
UREA	O
N-28*	O
CREAT-1.4*	O
SODIUM-137	O
POTASSIUM-5.7*	O
CHLORIDE-107	O
TOTAL	O
CO2-20*	O
ANION	O
GAP-16	O
___	O
09:51PM	O
estGFR-Using	O
this	O
___	O
09:51PM	O
WBC-9.3	O
RBC-4.53*	O
HGB-12.1*	O
HCT-35.1*	O
MCV-77*	O
MCH-26.6*	O
MCHC-34.4	O
RDW-15.0	O
___	O
09:51PM	O
PLT	O
COUNT-168	O
___	O
09:51PM	O
___	O
___	O
06:55PM	O
TYPE-ART	O
RATES-___/	O
TIDAL	O
VOL-600	O
O2-50	O
PO2-133*	O
PCO2-33*	O
PH-7.38	O
TOTAL	O
CO2-20*	O
BASE	O
XS--4	O
INTUBATED-INTUBATED	O
VENT-CONTROLLED	O
___	O
06:55PM	O
GLUCOSE-156*	O
LACTATE-2.8*	O
NA+-132*	O
K+-5.6*	O
___	O
06:55PM	O
HGB-11.3*	O
calcHCT-34	O
___	O
06:55PM	O
freeCa-1.02*	O
___	O
05:51PM	O
TYPE-ART	O
TEMP-37	O
RATES-/10	O
TIDAL	O
VOL-580	O
O2-50	O
PO2-163*	O
PCO2-38	O
PH-7.36	O
TOTAL	O
CO2-22	O
BASE	O
XS--3	O
INTUBATED-INTUBATED	O
VENT-CONTROLLED	O
___	O
05:51PM	O
GLUCOSE-154*	O
LACTATE-2.8*	O
NA+-133	O
K+-5.7*	O
CL--103	O
TCO2-20*	O
___	O
05:51PM	O
HGB-12.5*	O
calcHCT-38	O
___	O
05:51PM	O
freeCa-1.08*	O
___	O
05:51PM	O
freeCa-1.08*	O
___	O
04:22PM	O
TYPE-ART	O
TEMP-36.8	O
RATES-/10	O
TIDAL	O
VOL-570	O
O2-50	O
PO2-173*	O
PCO2-40	O
PH-7.36	O
TOTAL	O
CO2-24	O
BASE	O
XS--2	O
INTUBATED-INTUBATED	O
___	O
04:22PM	O
HGB-10.8*	O
calcHCT-32	O
O2	O
SAT-99	O
___	O
04:22PM	O
freeCa-1.10*	O
___	O
03:20PM	O
TYPE-ART	O
PO2-125*	O
PCO2-42	O
PH-7.37	O
TOTAL	O
CO2-25	O
BASE	O
XS-0	O
___	O
03:20PM	O
GLUCOSE-161*	O
LACTATE-1.8	O
NA+-133	O
K+-5.5*	O
CL--103	O
___	O
03:20PM	O
HGB-12.2*	O
calcHCT-37	O
O2	O
SAT-97	O
___	O
03:20PM	O
freeCa-1.11*	O
___	O
01:11PM	O
TYPE-ART	O
PO2-189*	O
PCO2-40	O
PH-7.40	O
TOTAL	O
CO2-26	O
BASE	O
XS-0	O
___	O
01:11PM	O
GLUCOSE-161*	O
LACTATE-1.3	O
NA+-133	O
K+-5.2*	O
CL--103	O
___	O
01:11PM	O
HGB-13.5*	O
calcHCT-41	O
O2	O
SAT-98	O
___	O
01:11PM	O
freeCa-1.12	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
presented	O
with	O
a	O
newly	O
diagnosed	O
duodenal	O
mass	O
and	O
admitted	O
to	O
the	O
HPB	O
Surgical	O
Service	O
for	O
elective	O
surgical	O
resection.	O
On	O
___,	O
the	O
patient	O
underwent	O
pylorus	O
sparing	O
radical	O
pancreatoduodenectomy.	O
Secondary	O
to	O
large	O
blood	O
loss	O
and	O
pressors	O
requirement,	O
patient	O
was	O
transferred	O
in	O
ICU	O
post	O
operatively,	O
intubated.	O
He	O
received	O
2	O
units	O
of	O
pRBC	O
intraoperatively.	O
On	O
POD	O
1	O
patient	O
was	O
extubated,	O
he	O
received	O
10	O
mg	O
of	O
vitamin	O
K	O
for	O
increased	O
INR.	O
On	O
POD	O
2	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
NPO,	O
on	O
IV	O
fluids,	O
with	O
a	O
foley	O
catheter,	O
and	O
Dilaudid	O
PCA	O
for	O
pain	O
control.	O
The	O
patient	O
was	O
hemodynamically	O
stable.	O
Neuro:	O
The	O
patient	O
received	O
Dilaudid	O
PCA	O
with	O
good	O
effect	O
and	O
adequate	O
pain	O
control.	O
When	O
tolerating	O
oral	O
intake,	O
the	O
patient	O
was	O
transitioned	O
to	O
oral	O
pain	O
medications.	O
CV:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
cardiovascular	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
Pulmonary:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
pulmonary	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
Good	O
pulmonary	O
toilet,	O
early	O
ambulation	O
and	O
incentive	O
spirrometry	O
were	O
encouraged	O
throughout	O
hospitalization.	O
GI/GU:	O
Post-operatively,	O
the	O
patient	O
was	O
made	O
NPO	O
with	O
IV	O
fluids.	O
NGT	O
was	O
removed	O
on	O
POD	O
1	O
and	O
G-tube	O
was	O
capped	O
on	O
POD	O
4.	O
Patient	O
was	O
started	O
on	O
sips	O
of	O
clears	O
and	O
tubefeed	O
on	O
POD	O
5.	O
Tubefeed	O
(Jevity	O
1.5)	O
was	O
advanced	O
to	O
goal	O
and	O
started	O
to	O
cycle	O
on	O
POD	O
7.	O
Patient	O
developed	O
diarrhea	O
and	O
bloating	O
on	O
Jevity	O
and	O
tubefeed	O
formula	O
was	O
changed	O
to	O
home	O
formula,	O
Promote	O
with	O
fiber,	O
which	O
was	O
well	O
tolerated.	O
Diet	O
was	O
advanced	O
to	O
regular	O
on	O
POD	O
8,	O
patient	O
demonstrated	O
inadequate	O
PO	O
intake	O
and	O
will	O
required	O
tubefeed	O
after	O
discharge.	O
JP's	O
output	O
was	O
tested	O
for	O
amylase	O
twice	O
on	O
POD	O
3	O
and	O
POD	O
6,	O
JP	O
amylase	O
from	O
JP	O
2	O
was	O
high	O
concerning	O
for	O
pancreatic	O
leak.	O
JP	O
1	O
was	O
discontinued	O
prior	O
discharge,	O
JP	O
2	O
was	O
left	O
in	O
place	O
after	O
discharge.	O
Patient's	O
PTBD	O
catheter	O
was	O
capped	O
on	O
POD	O
7,	O
LFTs	O
were	O
within	O
normal	O
limits	O
after	O
capping	O
PTBD.	O
Patient's	O
intake	O
and	O
output	O
were	O
closely	O
monitored,	O
and	O
IV	O
fluid	O
was	O
adjusted	O
when	O
necessary.	O
Electrolytes	O
were	O
routinely	O
followed,	O
and	O
repleted	O
when	O
necessary.	O
Patient	O
creatinine	O
bumped	O
to	O
2.0	O
from	O
1.0	O
on	O
POD	O
14	O
with	O
adequate	O
response	O
to	O
fluids.	O
Last	O
creatinine	O
checked	O
on	O
___	O
was	O
1.5	O
trending	O
down	O
from	O
1.8.	O
ID:	O
The	O
patient's	O
white	O
blood	O
count	O
and	O
fever	O
curves	O
were	O
closely	O
watched	O
for	O
signs	O
of	O
infection.	O
WBC	O
was	O
elevated	O
post	O
op,	O
thought	O
to	O
be	O
secondary	O
to	O
pancreatic	O
leak.	O
WBC	O
returned	O
to	O
normal	O
as	O
output	O
from	O
JP	O
2	O
decreased.	O
Wound	O
was	O
evaluated	O
daily	O
and	O
small	O
serosanguinous	O
drainage	O
was	O
noticed	O
on	O
POD	O
5.	O
Dry	O
dressing	O
was	O
applied	O
daily	O
on	O
this	O
area,	O
no	O
signs	O
or	O
symptoms	O
of	O
infection	O
were	O
noticed.	O
Endocrine:	O
The	O
patient's	O
blood	O
sugar	O
was	O
monitored	O
throughout	O
his	O
stay;	O
insulin	O
dosing	O
was	O
adjusted	O
accordingly.	O
Hematology:	O
Intraoperatively	O
patient	O
received	O
2	O
units	O
of	O
RBC.	O
Post	O
op	O
patient's	O
complete	O
blood	O
count	O
was	O
examined	O
routinely;	O
no	O
transfusions	O
were	O
required.	O
Prophylaxis:	O
The	O
patient	O
received	O
subcutaneous	O
heparin	O
and	O
venodyne	O
boots	O
were	O
used	O
during	O
this	O
stay;	O
was	O
encouraged	O
to	O
get	O
up	O
and	O
ambulate	O
as	O
early	O
as	O
possible.	O
He	O
was	O
started	O
on	O
Lovenox	O
prior	O
discharge	O
for	O
30	O
day	O
as	O
post	O
operative	O
DVT	O
prophylaxis.	O
At	O
the	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
doing	O
well,	O
afebrile	O
with	O
stable	O
vital	O
signs.	O
The	O
patient	O
was	O
tolerating	O
sips	O
with	O
meds	O
and	O
tubefeed	O
at	O
goal,	O
rate	O
115ml/hr,	O
ambulating,	O
voiding	O
without	O
assistance,	O
and	O
pain	O
was	O
well	O
controlled.	O
The	O
patient	O
received	O
discharge	O
teaching	O
and	O
follow-up	O
instructions	O
with	O
understanding	O
verbalized	O
and	O
agreement	O
with	O
the	O
discharge	O
plan.	O
Medications	O
on	O
Admission:	O
1.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
2.	O
Carvedilol	O
25	O
mg	O
PO	O
BID	O
3.	O
Simvastatin	O
40	O
mg	O
PO	O
QPM	O
4.	O
Losartan	O
Potassium	O
25	O
mg	O
PO	O
DAILY	O
5.	O
Allopurinol	O
___	O
mg	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
2.	O
Carvedilol	O
25	O
mg	O
PO	O
BID	O
3.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
4.	O
Enoxaparin	O
Sodium	O
40	O
mg	O
SC	O
DAILY	O
for	O
30	O
days,	O
post	O
operative	O
DVT	O
prophylaxis	O
5.	O
Glargine	O
10	O
Units	O
Lunch	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
6.	O
Losartan	O
Potassium	O
25	O
mg	O
PO	O
DAILY	O
7.	O
Octreotide	O
Acetate	O
200	O
mcg	O
SC	O
Q8H	O
Please	O
take	O
as	O
directed	O
8.	O
OxycoDONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q4H:PRN	O
pain	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
9.	O
Simvastatin	O
40	O
mg	O
PO	O
QPM	O
10.	O
Metoclopramide	O
10	O
mg	O
PO	O
QID	O
11.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
12.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Adenocarcinoma	O
of	O
the	O
ampulla	O
of	O
Vater	O
(pT4N1)	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent	B-Independently_mobile
with	O
minimal	O
assist	B-Mobile_with_assistance
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
the	O
surgery	O
service	O
at	O
___	O
for	O
surgical	O
resection	O
of	O
a	O
dudoneal	O
mass	O
at	O
the	O
ampulla	O
of	O
Vater.	O
You	O
underwent	O
a	O
___	O
procedure	O
on	O
___	O
which	O
was	O
complicated	O
by	O
a	O
leakage	O
managed	O
with	O
drainage,	O
now	O
resolving.	O
You	O
have	O
recovered	O
well	O
in	O
the	O
post	O
operative	O
period	O
and	O
you	O
will	O
continue	O
your	O
recovery	O
process	O
at	O
a	O
rehabilitation	O
facility	O
with	O
the	O
following	O
instructions:	O
Please	O
resume	O
all	O
regular	O
home	O
medications	O
,	O
unless	O
specifically	O
advised	O
not	O
to	O
take	O
a	O
particular	O
medication.	O
Also,	O
please	O
take	O
any	O
new	O
medications	O
as	O
prescribed.	O
Please	O
continue	O
Octreotide	O
200mg	O
tid	O
unless	O
told	O
otherwise.	O
Avoid	O
driving	O
or	O
operating	O
heavy	O
machinery	O
while	O
taking	O
pain	O
medications.	O
Please	O
continue	O
with	O
tube	O
feeding	O
with	O
your	O
home	O
formula	O
at	O
a	O
rate	O
of	O
115	O
ml/hr.	O
Please	O
see	O
below	O
for	O
more	O
detailed	O
instructions.	O
Incision	O
Care:	O
*Change	O
dressing	O
daily	O
and	O
prn.	O
*Please	O
call	O
your	O
doctor	O
or	O
nurse	O
practitioner	O
if	O
you	O
have	O
increased	O
pain,	O
swelling,	O
redness,	O
or	O
drainage	O
from	O
the	O
incision	O
site.	O
*Avoid	O
swimming	O
and	O
baths	O
until	O
your	O
follow-up	O
appointment.	O
*You	O
may	O
shower,	O
and	O
wash	O
surgical	O
incisions	O
with	O
a	O
mild	O
soap	O
and	O
warm	O
water.	O
Gently	O
pat	O
the	O
area	O
dry.	O
*If	O
you	O
have	O
staples,	O
they	O
will	O
be	O
removed	O
at	O
your	O
follow-up	O
appointment.	O
*If	O
you	O
have	O
steri-strips,	O
they	O
will	O
fall	O
off	O
on	O
their	O
own.	O
Please	O
remove	O
any	O
remaining	O
strips	O
___	O
days	O
after	O
surgery.	O
JP	O
Drain	O
Care:	O
*Please	O
look	O
at	O
the	O
site	O
every	O
day	O
for	O
signs	O
of	O
infection	O
(increased	O
redness	O
or	O
pain,	O
swelling,	O
odor,	O
yellow	O
or	O
bloody	O
discharge,	O
warm	O
to	O
touch,	O
fever).	O
*Maintain	O
suction	O
of	O
the	O
bulb.	O
*Note	O
color,	O
consistency,	O
and	O
amount	O
of	O
fluid	O
in	O
the	O
drain.	O
Call	O
the	O
doctor,	O
___,	O
or	O
___	O
nurse	O
if	O
the	O
amount	O
increases	O
significantly	O
or	O
changes	O
in	O
character.	O
*Be	O
sure	O
to	O
empty	O
the	O
drain	O
frequently.	O
Record	O
the	O
output,	O
if	O
instructed	O
to	O
do	O
so.	O
*You	O
may	O
shower;	O
wash	O
the	O
area	O
gently	O
with	O
warm,	O
soapy	O
water.	O
*Keep	O
the	O
insertion	O
site	O
clean	O
and	O
dry	O
otherwise.	O
*Avoid	O
swimming,	O
baths,	O
hot	O
tubs;	O
do	O
not	O
submerge	O
yourself	O
in	O
water.	O
*Make	O
sure	O
to	O
keep	O
the	O
drain	O
attached	O
securely	O
to	O
your	O
body	O
to	O
prevent	O
pulling	O
or	O
dislocation.	O
Gastrostomy/jejunostomy-tube	O
care	O
and	O
tube	O
feeding:	O
*Keep	O
your	O
Gastrostomy	O
(G-tube)	O
capped.	O
Is	O
ok	O
to	O
vent	O
the	O
G-tube	O
if	O
feeling	O
nauseated	O
during	O
the	O
morning.	O
*Please	O
use	O
Jejunostomy	O
(J-tube)	O
for	O
route	O
of	O
tube	O
feeding.	O
Please	O
cycle	O
feeds	O
during	O
18	O
hrs	O
and	O
flush	O
with	O
50	O
cc	O
of	O
water	O
every	O
8	O
hours.	O
*Monitor	O
for	O
signs	O
and	O
symptoms	O
of	O
infection	O
or	O
dislocation.	O
*Change	O
drain	O
sponge	O
daily	O
and	O
prn.	O
Please	O
get	O
plenty	O
of	O
rest,	O
continue	O
to	O
ambulate	O
several	O
times	O
per	O
day,	O
and	O
drink	O
adequate	O
amounts	O
of	O
fluids.	O
Avoid	O
lifting	O
weights	O
greater	O
than	O
___	O
lbs	O
until	O
you	O
follow-up	O
with	O
your	O
surgeon,	O
who	O
will	O
instruct	O
you	O
further	O
regarding	O
activity	O
restrictions.	O
Please	O
follow-up	O
with	O
your	O
surgeon	O
and	O
Primary	O
Care	O
Provider	O
(PCP)	O
as	O
advised.	O
Please	O
call	O
Dr.	O
___	O
office	O
at	O
___	O
if	O
you	O
have	O
any	O
questions	O
or	O
concerns.	O
*You	O
experience	O
new	O
chest	O
pain,	O
pressure,	O
squeezing	O
or	O
tightness.	O
*New	O
or	O
worsening	O
cough,	O
shortness	O
of	O
breath,	O
or	O
wheeze.	O
*If	O
you	O
are	O
vomiting	O
and	O
cannot	O
keep	O
down	O
fluids	O
or	O
your	O
medications.	O
*You	O
are	O
getting	O
dehydrated	O
due	O
to	O
continued	O
vomiting,	O
diarrhea,	O
or	O
other	O
reasons.	O
Signs	O
of	O
dehydration	O
include	O
dry	O
mouth,	O
rapid	O
heartbeat,	O
or	O
feeling	O
dizzy	O
or	O
faint	O
when	O
standing.	O
*You	O
see	O
blood	B-Upper_gastrointestinal_haemorrhage
or	B-Upper_gastrointestinal_haemorrhage
dark/black	B-Upper_gastrointestinal_haemorrhage
material	B-Upper_gastrointestinal_haemorrhage
when	O
you	O
vomit	B-Upper_gastrointestinal_haemorrhage
or	O
have	O
a	O
bowel	B-Lower_gastrointestinal_haemorrhage
movement.	O
*You	O
experience	O
burning	O
when	O
you	O
urinate,	O
have	O
blood	O
in	O
your	O
urine,	O
or	O
experience	O
a	O
discharge.	O
*Your	O
pain	O
in	O
not	O
improving	O
within	O
___	O
hours	O
or	O
is	O
not	O
gone	O
within	O
24	O
hours.	O
Call	O
or	O
return	O
immediately	O
if	O
your	O
pain	O
is	O
getting	O
worse	O
or	O
changes	O
location	O
or	O
moving	O
to	O
your	O
chest	O
or	O
back.	O
*You	O
have	O
shaking	O
chills,	O
or	O
fever	O
greater	O
than	O
101.5	O
degrees	O
Fahrenheit	O
or	O
38	O
degrees	O
Celsius.	O
*Any	O
change	O
in	O
your	O
symptoms,	O
or	O
any	O
new	O
symptoms	O
that	O
concern	O
you.	O
Followup	O
Instructions:	O
___	O

